Platelets as immune cells - Bridging inflammation and cardiovascular disease

被引:565
作者
von Hundelshausen, Philipp [1 ]
Weber, Christian [1 ]
机构
[1] Univ Hosp, Rhein Westfal TH Aachen, Inst Cardiovasc Mol Res, D-5100 Aachen, Germany
关键词
platelets; inflammation; cardiovascular disease; chemokines; adhesion molecules;
D O I
10.1161/01.RES.0000252802.25497.b7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Beyond an eminent role in hemostasis and thrombosis, platelets are characterized by expert functions in assisting and modulating inflammatory reactions and immune responses. This is achieved by the regulated expression of adhesive and immune receptors on the platelet surface and by the release of a multitude of secretory products including inflammatory mediators and cytokines, which can mediate the interaction with leukocytes and enhance their recruitment. In addition, platelets are characterized by an enormous surface area and open canalicular system, which in concert with specialized recognition receptors may contribute to the engulfment of serum components, antigens, and pathogens. Platelet-dependent increases in leukocyte adhesion may not only account for an exacerbation of atherosclerosis, for arterial repair processes, but also for lymphocyte trafficking during adaptive immunity and host defense. This review compiles a selection of platelet-derived tools for bridging inflammation and vascular disease and highlights the molecular key components governing platelet-mediated mechanisms operative in immune surveillance, vascular remodeling, and atherosclerosis.
引用
收藏
页码:27 / 40
页数:14
相关论文
共 203 条
[1]   The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques [J].
Abi-Younes, S ;
Sauty, A ;
Mach, F ;
Sukhova, GK ;
Libby, P ;
Luster, AD .
CIRCULATION RESEARCH, 2000, 86 (02) :131-138
[2]   The CC chemokines MDC and TARC induce platelet activation via CCR4 [J].
Abi-Younes, S ;
Si-Tahar, M ;
Luster, AD .
THROMBOSIS RESEARCH, 2001, 101 (04) :279-289
[3]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[4]   Platelets express functional Toll-like receptor-4 [J].
Andonegui, G ;
Kerfoot, SM ;
McNagny, K ;
Ebbert, KVJ ;
Patel, KD ;
Kubes, P .
BLOOD, 2005, 106 (07) :2417-2423
[5]   CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J].
André, P ;
Prasad, KSS ;
Denis, CV ;
He, M ;
Papalia, JM ;
Hynes, RO ;
Phillips, DR ;
Wagner, DD .
NATURE MEDICINE, 2002, 8 (03) :247-252
[6]   Interleukin-1 receptor antagonist: Role in biology [J].
Arend, WP ;
Malyak, M ;
Guthridge, CJ ;
Gabay, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :27-55
[7]   The balance between IL-1 and IL-1Ra in disease [J].
Arend, WR .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :323-340
[8]   IDENTIFICATION OF A SOURCE OF BIOLOGICALLY-ACTIVE CD40 LIGAND [J].
ARMITAGE, RJ ;
SATO, TA ;
MACDUFF, BM ;
CLIFFORD, KN ;
ALPERT, AR ;
SMITH, CA ;
FANSLOW, WC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) :2071-2076
[9]   Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo [J].
Aslam, R ;
Speck, ER ;
Kim, M ;
Crow, AR ;
Bang, KWA ;
Nestel, FP ;
Ni, HY ;
Lazarus, AH ;
Freedman, J ;
Semple, JW .
BLOOD, 2006, 107 (02) :637-641
[10]   Rolling of Th1 cells via p-selectin glycoprotein ligand-1 stimulates LFA-1-Mediated cell binding to ICAM-1 [J].
Atarashi, K ;
Hirata, T ;
Matsumoto, M ;
Kanemitsu, N ;
Miyasaka, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (03) :1424-1432